Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

SIMOLA, NICOLA;MORELLI, MICAELA;TRONCI, ELISABETTA;CARTA, MANOLO;
2015-01-01

Abstract

Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa) therapy for Parkinson's disease (PD). L-dopa-induced dyskinesia (LID) are ultimately experienced by the vast majority of patients. In addition, psychiatric conditions often manifested as compulsive behaviours, are emerging as a serious problem in the management of L-dopa therapy. The present review attempts to provide an overview of our current understanding of dyskinesia and other L-dopa-induced dysfunctions, a field that dramatically evolved in the past twenty years. In view of the extensive literature on LID, there appeared a critical need to re-frame the concepts, to highlight the most suitable models, to review the central nervous system (CNS) circuitry that may be involved, and to propose a pathophysiological framework was timely and necessary. An updated review to clarify our understanding of LID and other L-dopa-related side effects was therefore timely and necessary. This review should help in the development of novel therapeutic strategies aimed at preventing the generation of dyskinetic symptoms
2015
Animal models, D1 receptor, Dopamine, Dyskinesia, L-dopa, Parkinson's disease
Files in This Item:
File Size Format  
Bastide et al Prog Neurobiol 2015.pdf

Solo gestori archivio

Type: versione editoriale
Size 3.72 MB
Format Adobe PDF
3.72 MB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie